Using Magnetocardiography to Assess Chest Pain Risks
Official title: Magnetocardiography in the Identification and Risk Stratification of Patients With Acute Chest Pian
Run by Qilu Hospital of Shandong University · NCT06316011 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study tests if a special heart scan can help doctors understand the risks of chest pain in people who might have a serious heart condition.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 3620 (estimated) |
| Sponsor | Qilu Hospital of Shandong University Academic / other |
| Locations | 1 site (Jinan, Shandong) |
| Trial ID | NCT06316011 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals presenting with symptoms of acute chest pain suspected of acute coronary syndrome.
✕Probably not a fit
Patients with known structural heart disease, significant arrhythmias, or other critical conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify and stratify the risk of patients presenting with acute chest pain suspected of having acute coronary syndrome (ACS) using Magnetocardiography (MCG). The study will involve a prospective cohort of patients who meet specific inclusion criteria, including those with suspected ACS. Participants will undergo MCG examinations to evaluate their cardiac function and risk levels. The findings may help in better management and treatment decisions for patients with chest pain.
Why it matters
Potential benefit: If successful, this approach could lead to improved risk assessment and management of patients with acute chest pain, potentially reducing adverse outcomes.
How similar studies have gone: While the use of Magnetocardiography is a relatively novel approach, similar studies in cardiac risk assessment have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Those with suspected ACS who presented with symptoms of acute chest pain. * Signed informed consent. Exclusion Criteria: * Those with known structural heart disease such as cardiomyopathy and valvular disease; * Those with atrial fibrillation, supraventricular tachycardia, atrioventricular block and other arrhythmias that have not returned to normal; * Those who have chest pain with known pulmonary embolism or aortic coarctation; * Those who are thought to be incapable of completing the MCG examination by an attending physician (or physician with higher qualifications) due to unstable clinical conditions, metal implants, etc; * Those who are unable to perform magnetocardiography examinations due to claustrophobia, etc., or those who fail to receive magnetocardiography examination; * Those with malignant tumors; * Pregnant or lactating women. * Those with acute or critical illnesses of other systems, such as acute or severe respiratory illnesses, marked abnormalities in liver function or kidney function.
Where it's running
-
Qilu Hospital of Shandong University
Jinan, Shandong, China Recruiting
Study contacts
- Principal investigator: Yuguo Chen, Professor — Qliu Hospital of Shandong University
- Study coordinator: Jiaojiao Pang, Doctor
- Email: jiaojiaopang@126.com
- Phone: 0086-0531-82165674
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Common femoral vein-to-artery diameter ratio to detect elevated LVEDP
Researchers test whether the ratio of the common femoral vein to artery diameters, measured by ultrasound, can flag elevated LV end-diastolic pressure in patients having coronary angiography.
-
Intrahospital flu vaccine for adults with high cardiovascular risk when admitted for ACS or heart failure
This study tests whether offering a flu vaccine at the bedside during a hospital stay, along with counseling, increases vaccination rates for adults with acute coronary syndrome or heart failure who are at high cardiovascular risk.
-
Digital lifestyle platform after rehabilitation to support self-management
A digital, patient-facing platform is being tested to see if people who recently finished inpatient rehabilitation will use it and benefit from personalized lifestyle guidance at home.
-
AI-driven Medipixel fractional flow reserve to guide PCI
This test checks whether an AI-based, angiography-derived Medipixel FFR method can guide PCI as safely and effectively as standard invasive pressure-wire FFR in adults with coronary artery disease.
-
Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions
This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.
-
AI-assisted interpretation of chest pain CT in the emergency department
A pragmatic randomized trial tests whether an AI tool (Angiomics) helps emergency physicians interpret coronary CT angiography in adults with acute chest pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.